NPPA found out that average trade margin range from 211 percent to 449 percent in certain orthopaedic knee implants.
After the cap on stent pricing, it may be the turn of orthopaedic knee implants. Drug pricing regulator NPPA (National Pharmaceutical Pricing Authority) has released a list of prices and trade margins for orthopaedic knee implants.
Earlier in February, when NPPA brought cardiac stents under price control, it had said that it has been closely monitoring and collecting market data on 13 other medical devices that have been categorised as drugs and are under the price control at DPCO 2013 (Drug Price Control Order).
NPPA has analysed and compared the minimum and maximum landed price of five different categories of orthopaedic knee implants — femoral, tribal plate, insert, patella and total knee system. It found out that average trade margin range from 211 percent to 449 percent in certain orthopaedic knee implants.
Hospitals and distributors were accounting for the highest mark-ups in orthopaedic knee implants, ranging from 120 percent to 163 percent. The patients were charged Rs 4,13,059 as MRP for a total knee systems having a maximum landed price of Rs 65,781.The Authority has sought a response from the manufacturers on the issue in a week's time.